Morgan Stanley Institutional Vitality Portfolio (MSVEX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
6.48
0.00 (0.00%)
Jul 2, 2026, 9:30 AM EST
MSVEX Holdings Information
MSVEX is a mutual fund with a total of 33 individual holdings. The top holdings are argenx SE stock at 8.03%, Eli Lilly and Company at 7.79%, Ascendis Pharma at 5.48%, Nektar Therapeutics at 4.75%, and Thermo Fisher Scientific at 4.28%.
Total Holdings
33
Top 10 Percentage
49.09%
Asset Class
Equity
Fund Category
Health
Assets
2.00M
Forward PE Ratio
24.43
Breakdown by Asset Class
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ARGX | argenx SE | 8.03% |
| 2 | LLY | Eli Lilly and Company | 7.79% |
| 3 | ASND | Ascendis Pharma A/S | 5.48% |
| 4 | NKTR | Nektar Therapeutics | 4.75% |
| 5 | TMO | Thermo Fisher Scientific Inc. | 4.28% |
| 6 | ALGN | Align Technology, Inc. | 4.18% |
| 7 | ELVN | Enliven Therapeutics, Inc. | 3.90% |
| 8 | TXG | 10x Genomics, Inc. | 3.77% |
| 9 | NAMS | NewAmsterdam Pharma Company N.V. | 3.57% |
| 10 | GPCR | Structure Therapeutics Inc. | 3.36% |
| 11 | CBLL | CeriBell, Inc. | 3.36% |
| 12 | DOCS | Doximity, Inc. | 2.93% |
| 13 | ISRG | Intuitive Surgical, Inc. | 2.85% |
| 14 | GH | Guardant Health, Inc. | 2.73% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.71% |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 2.67% |
| 17 | PCVX | Vaxcyte, Inc. | 2.59% |
| 18 | ILMN | Illumina, Inc. | 2.52% |
| 19 | INSP | Inspire Medical Systems, Inc. | 2.48% |
| 20 | ZTS | Zoetis Inc. | 2.27% |
| 21 | UNH | UnitedHealth Group Incorporated | 2.18% |
| 22 | KYMR | Kymera Therapeutics, Inc. | 2.08% |
| 23 | DXCM | DexCom, Inc. | 1.99% |
| 24 | BEAM | Beam Therapeutics Inc. | 1.79% |
| 25 | WST | West Pharmaceutical Services, Inc. | 1.71% |
As of Mar 31, 2026